DK0420264T3 - Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on - Google Patents

Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on

Info

Publication number
DK0420264T3
DK0420264T3 DK90118673.4T DK90118673T DK0420264T3 DK 0420264 T3 DK0420264 T3 DK 0420264T3 DK 90118673 T DK90118673 T DK 90118673T DK 0420264 T3 DK0420264 T3 DK 0420264T3
Authority
DK
Denmark
Prior art keywords
benzothiazepine
acetoxy
dimethylaminoethyl
methoxyphenyl
dihydro
Prior art date
Application number
DK90118673.4T
Other languages
English (en)
Inventor
Prakash R Keshary
Donna R Jones
James W Mitchell
Original Assignee
Marion Merrell Dow Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Inc filed Critical Marion Merrell Dow Inc
Application granted granted Critical
Publication of DK0420264T3 publication Critical patent/DK0420264T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90118673.4T 1989-09-29 1990-09-28 Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on DK0420264T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/414,381 US5002773A (en) 1989-09-29 1989-09-29 Transdermal delivery of (+) (2S,3S)-3-acetoxy-8-chloro-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4-(5H)-one

Publications (1)

Publication Number Publication Date
DK0420264T3 true DK0420264T3 (da) 1991-06-19

Family

ID=23641207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90118673.4T DK0420264T3 (da) 1989-09-29 1990-09-28 Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on

Country Status (6)

Country Link
US (1) US5002773A (da)
EP (1) EP0420264A3 (da)
JP (1) JPH03157332A (da)
AU (1) AU628660B2 (da)
CA (1) CA2026293A1 (da)
DK (1) DK0420264T3 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963545A (en) * 1988-05-24 1990-10-16 Marion Laboratories, Inc. Benzothiazepine anti-seizure method
US5383848A (en) * 1990-04-12 1995-01-24 Gensia, Inc. Iontophoretic administration of drugs
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
EP1532115A4 (en) * 2002-05-22 2006-01-11 Smithkline Beecham Corp INHIBITORS OF PROTEASE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures

Also Published As

Publication number Publication date
AU6364490A (en) 1991-04-11
US5002773A (en) 1991-03-26
AU628660B2 (en) 1992-09-17
JPH03157332A (ja) 1991-07-05
CA2026293A1 (en) 1991-03-30
EP0420264A2 (en) 1991-04-03
EP0420264A3 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
DK19388D0 (da) Fremmstilling af aromatiske, heterocykliske polymerer
DK177690D0 (da) Behandling af fedme
DK112387A (da) Rensning af alfa-1-antiprotease
DK662687A (da) Anvendelse af tricycliske carbazoloner
DK0420264T3 (da) Transdermal indgivelse af (+)(2S,3S)-3-acetoxy-8-chlor-5-(2-dimethylaminoethyl)-2,3-dihydro-2-(4- methoxyphenyl)-1,5-benzothiazepin-4-(5H)-on
DK1066292T3 (da) Metallocorrinoider som biologisk kompatible bærere af farmakologiske midler
DE69111915D1 (de) Pyrido(2,3-f)(1,4)thiazepine und Pyrido(3,2-b)(1,5)benzothiazepine.
DK0875579T3 (da) Fremstilling af L(+)-laktat
DK199587A (da) Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner
DK0941081T3 (da) Ny anvendelse af creatin
DK199487D0 (da) Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner
IT9022340A0 (it) Processo per la preparazione del (+)-cis-3-(acetossi)-5-(2-(dimetilammino)etil)-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato.
DK80990A (da) Sulfonylderivater af thien-triazol-diazepin
DK120389A (da) Anvendelse af progestin
ES2023774A6 (es) Procedimiento para la preparacion del intermedio de diltiazem.
DK104389A (da) Anvendelse af imidazolderivater
ATE227733T1 (de) Herstellung von avermectin-verbindungen
DK681088D0 (da) Ae3-hydroxy-2(4-methoxyphenyl)-5-(2-methylaminoethyl)-2,3-dihydro-1,5-5h-benzothiazepin-4-on-derivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne derivaterae
DK104489A (da) Anvendelse af triazolderivater
SE9002410D0 (sv) Foerfarande foer rening av mellanprodukter
IT8521855A0 (it) Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato
IT1237204B (it) Procedimento per la preparazione di 2-aril-3-idrossi-cis-2,3-diidro- 1,5-benzotiazepin-4(5h)-oni e derivati
DK0882722T3 (da) Fremstilling af alpha-tocopherol
IT8422701A0 (it) Procedimento per il recupero delcis(+)-3-acetilossi-5-[2-(dimetilammino)etil]-2,3-diidro-2-(4-metossifenil)-1,5-benzotiazepin-4-(5h)-one cloridrato
DK732088A (da) Fremgangsmaade til fremstilling af 1,5-benzothiazepinderivater